Not applicableUnknownNCT04712201What this trial is testingEn Bloc Bladder Tumor Resection: Prospective Randomized StudyWho this might be right forUrothelial Carcinoma BladderBladder Cancer Fundacio Puigvert 300
Early research (Phase 1)Study completedNCT00694798What this trial is testingStudy of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of BladderWho this might be right forBladder Cancer Cadila Pharnmaceuticals 22
Testing effectiveness (Phase 2)Looking for participantsNCT06503614What this trial is testingA Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial Carcinoma John Sfakianos 60
Testing effectiveness (Phase 2)Looking for participantsNCT06184516What this trial is testingAssessment of Decision Tool to Select Women for Gynecologic Sparing Radical CystectomyWho this might be right forUrothelial Carcinoma Bladder University of Florida 127
Testing effectiveness (Phase 2)Ended earlyNCT00089128What this trial is testingGemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerWho this might be right forBladder Cancer Medical University of South Carolina 16
Large-scale testing (Phase 3)UnknownNCT00553124What this trial is testingDifferent Factors Affecting Patients With Newly Diagnosed Bladder CancerWho this might be right forBladder Cancer University Hospital Birmingham 3,400
Testing effectiveness (Phase 2)Study completedNCT00963859What this trial is testingRobotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the BladderWho this might be right forBladder Cancer M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00088946What this trial is testingErlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Cancer Jonsson Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386746What this trial is testingIntravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder CancerWho this might be right forUrothelial Carcinoma BladderBladder Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Large-scale testing (Phase 3)Study completedNCT00022191What this trial is testingCisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 608
Early research (Phase 1)UnknownNCT01124682What this trial is testing3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the BladderWho this might be right forBladder Cancer Institute of Cancer Research, United Kingdom 60
Testing effectiveness (Phase 2)Ended earlyNCT01331824What this trial is testingTrial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial CarcinomaWho this might be right forBladder Cancer Matthew Galsky 22
Testing effectiveness (Phase 2)Study completedNCT03785925What this trial is testingA Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial CancerWho this might be right forUrinary Bladder NeoplasmNeoplasm Metastasis Nektar Therapeutics 192
Testing effectiveness (Phase 2)Ended earlyNCT05012397What this trial is testingMilademetan in Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more Rain Oncology Inc 40
Testing effectiveness (Phase 2)UnknownNCT00006118What this trial is testingCisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder CancerWho this might be right forBladder Cancer GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)Not Yet RecruitingNCT07217496What this trial is testingN-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial CancerWho this might be right forMetastatic Urothelial CarcinomaUrothelial CarcinomaLocally Advanced Urothelial Carcinoma+2 more ImmunityBio, Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06770582What this trial is testingTesting the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialWho this might be right forNon-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v8 National Cancer Institute (NCI) 160
Testing effectiveness (Phase 2)Study completedNCT02581982What this trial is testingPaclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial CancerWho this might be right forTransitional Cell Carcinoma Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Ended earlyNCT03912818What this trial is testingDurvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder CancerWho this might be right forBladder AdenocarcinomaBladder Mixed AdenocarcinomaBladder Squamous Cell Carcinoma+9 more Stanford University 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05200988What this trial is testingCheckpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UCWho this might be right forUrothelial CarcinomaBladder Cancer The Netherlands Cancer Institute 50